 |
Andrew Morris, M.Sc., MBAChief Financial Officer
Andrew joined the SQI Diagnostics team in 2004 as its CFO with the key deliverables of growing and enhancing the Company's financial position and corporate strategy. Andrew adds a well-rounded experience set gained in leadership roles in the areas of medical research, capital markets and corporate finance. Prior to joining SQI, Andrew led the Corporate Finance Life Sciences group at Ernst & Young, advising private and public companies on a variety of business strategy and financial matters including private equity offerings, mergers and acquisitions, and strategic alliances. Prior to that, Andrew gained considerable transaction experience while working in senior corporate development and finance roles in high growth and start-up companies. He also gained valuable capital markets and equity research experience at Scotia Capital, while covering companies in the Healthcare and Biotechnology sector. Andrew's background also includes eight years conducting research in the area of human performance enhancement at the Defence and Civil Institute of Environmental Medicine. Andrew holds an Honours Bachelor of Science from the University of Western Ontario, a Master's of Science from the Faculty of Medicine at the University of Toronto, and a Master's of Business Administration degree from the Rotman School of Management at the University of Toronto. With significant experience in turning around, shaping and building successful companies, this team forms the optimum executive roster to propel SQI Diagnostics forward. |
